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Are We Getting Closer to Solving a Diagnostic
and Therapeutic Dilemma?*Helmut Baumgartner, MDA ssessment of aortic stenosis (AS) severity hasbecome increasingly difﬁcult over recentyears. Current guidelines (1) deﬁne severe
AS by an aortic valve area (AVA) <1.0 cm2, and—at
normal ﬂow conditions—a peak transvalvular velocity
> 4 m/s and mean gradient >40 mm Hg. Besides the
still-challenging technical issues of measuring these
parameters accurately in clinical practice, diagnosis
of severe AS is easy when measurements of gradient
and AVA are consistent. However, this is frequently
not the case. It has been recognized for a long time
that severe AS may present with an AVA <1.0 cm2
but gradient <40 mm Hg when transvalvular ﬂow is
reduced and this has originally been described pri-
marily in patients with poor left ventricular function
(1). In this setting of “classical” low-ﬂow low-gradient
AS with reduced ejection fraction (EF), dobutamine
echocardiography (DE) has been demonstrated to be
helpful for further evaluation (1). The presence or
absence of “contractile reserve” (or “ﬂow reserve”),
which has been deﬁned as an increase in stroke vol-
ume of 20% or more on dobutamine, is then the ﬁrst
critical information. In the absence of contractile
reserve, no solid conclusions can be drawn with re-
gard to severity of AS, and the outcome of these pa-
tients will be poor (2). In the presence of a
contractile reserve, DE allows distinction of true se-
vere AS (ﬁxed small valve area, increase in gradient)
from pseudosevere AS (reduced valve opening of a
moderately diseased valve due primarily to impaired
driving forces, increase of valve area with increasing
ﬂow rate) (1). This information is critical as patients*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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whereas those with pseudosevere AS can be treated
conservatively (3).
Diagnosis and treatment of AS became more
complicated when the new entity of “paradoxical”
low-ﬂow low-gradient severe AS was introduced (4).
It refers to patients with preserved EF but, never-
theless, reduced transvalvular ﬂow (stroke volume
index <35 ml/m2). Typically, these patients present
with hypertrophied, small ventricles. There are,
however, other reasons why valve area may be
calculated <1.0 cm2 whereas gradients are me-
asured <40 mm Hg in the presence of normal EF (1).
Measurement errors are of particular concern and
include the systematic underestimation of left ven-
tricular outﬂow tract area and therefore ﬂow rate
and AVA when assuming a circular shape of the
commonly oval left ventricular outﬂow tract area in
the continuity equation (5). The group of AS patients
presenting with small AVA but low gradient in the
presence of normal EF is therefore likely to include
true severe AS as well as moderate AS. This may
explain why retrospective studies of this patient
group reported beneﬁt as well as missing beneﬁt from
aortic valve replacement (4,6). Further differentia-
tion and selection of those patients who indeed have
severe AS and should therefore undergo intervention
is critical. Little is known so far about the role of DE in
this situation. Although a small recent study has
suggested that DE may also be helpful in this setting
to differentiate between true severe and pseudose-
vere AS—similarly to low EF, low-gradient AS
(7)—there remain concerns whether such a test can
really be helpful in patients with small volume ven-
tricles and normal EF.SEE PAGE 1133The study by Chahal et al. (8) in this issue iJACC,
provides some important new information in this re-
gard. The investigators analyzed retrospectively the
data of 67 consecutive, symptomatic patients with AS
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1141presenting with AVA <1 cm2 but gradient <40 mm Hg
in the presence of either EF <50% or stroke volume
index #35 ml/m2 who had undergone stress echo-
cardiography (DE or physical stress). In patients with
a normal rest ﬂow rate deﬁned as $200 ml/s, AVA did
in general not increase beyond 1.0 cm2 on stress and
gradient increased to >40 mm Hg in most of them.
They concluded that low-gradient AS patients who
are found to have a ﬂow rate $200 ml/s will in general
have severe AS and do not require DE.
Whereas the study provides important new as-
pects, it also has major limitations that may preclude
translation into clinical practice.
The investigators argue correctly that for the
interpretation of a given transvalvular gradient and
AVA, one should look at the actual transvalvular ﬂow
rate rather than at stroke volume or stroke volume
index. Stroke volume may, for example, be normal
despite low-ﬂow rate when the ejection time is pro-
longed in severe AS. Which ﬂow rate should be
considered normal—200 ml/s as recommended in the
paper by Chahal et al. (8) or 250 ml/s as previously
proposed by the TOPAS (Truly or Pseudo-Severe
Aortic Stenosis) study group (9)—remains uncertain.
Chahal et al. (8) argue that 250 ml/s would result in an
already supra-normal cardiac output of 6.1 l/min at a
heart rate of 70 beats/min and a systolic ejection
period of 350 ms. However, they chose a pretty long
ejection time in this example. This may not be
appropriate in a situation where we would like to
distinguish between severe and nonsevere AS.
Assuming a normal or slightly prolonged ejection
time, 250 ml/s results indeed in a normal stroke vol-
ume and cardiac output.
More importantly, the investigators assumed true
severe AS when valve area remained <1.0 cm2 but
mean gradient increased beyond 40 mm Hg during
the test. However, the cutoff of 40 mm Hg has been
recommended for normal (or during a test normal-
ized) ﬂow conditions. If a patient presents with
low-gradient AS in the presence of a normal ﬂow
rate at rest, the ﬂow rate will increase to “supra-
normal” values during the stress test and mean
gradient may be higher than 40 mm Hg even in
moderate AS.Thus, the investigators can only conclude that in
their small series of patients with low-gradient AS
those with normal rest ﬂow rate were unlikely to have
an increase in valve area but were likely to have an
increase in gradient. Whether these patients indeed
have severe AS and beneﬁt from intervention remains
to be shown. Besides measurement errors that may
explain discordant values for valve area and gradient,
it has to be kept in mind that the generation of a
40 mm Hg gradient at normal ﬂow conditions re-
quires an AVA closer to 0.8 than 1.0 cm2. Should the
gradient cutoff or the one for AVA therefore be low-
ered to avoid discordance? It should also be kept in
mind that in clinical practice, gradient measurement
by echo is certainly more robust than AVA calculation
is, which is highly error-prone.
Outcome data would be desirable to support the
deﬁnition of severe AS and recommendations for
intervention. Currently available papers regarding
this subject are however limited by their retrospec-
tive nature and the questionable comparability of
patients with and without surgery despite attempts of
risk adjustment. Although beneﬁt from valve
replacement in low-gradient AS has also been re-
ported to be independent of ﬂow rate (10), more
studies found normal ﬂow, low-gradient AS to have
an outcome similar to moderate AS and no improve-
ment with surgery (6,11,12). A very recent paper (6)
even questions whether low-ﬂow, low-gradient AS
with normal EF has improved outcome with surgery,
although a number of previous retrospective papers
tried to demonstrate that (13).
Thus, low-gradient AS still remains a diagnostic
and therapeutic dilemma. Clinical as well as
morphologic information in addition to valve area
and gradient such as degree of valve calciﬁcation
(14,15) may be required for making proper decisions.
Further research is deﬁnitely required.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Helmut Baumgartner, Division of Adult Congenital
and Valvular Heart Disease, Department of Cardio-
vascular Medicine, University Hospital Muenster,
Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
E-mail: helmut.baumgartner@ukmuenster.de.RE F E RENCE S1. Baumgartner H, Hung J, Bermejo J, et al.
Echocardiographic assessment of valve stenosis:
EAE/ASE recommendations for clinical practice.
Eur J Echocardiogr 2009;10:1–25.
2. Monin JL, Quéré JP, Monchi M, et al.
Low-gradient aortic stenosis: operative risk
stratiﬁcation and predictors for long-termoutcome: a multicenter study using dobut-
amine stress hemodynamics. Circulation 2003;
108:319–24.
3. Fougères E, Tribouilloy C, Monchi M, et al.
Outcomes of pseudo-severe aortic stenosis under
conservative treatment. Eur Heart J 2012;33:
2426–33.4. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P.
Paradoxical low-ﬂow, low-gradient severe aortic
stenosis despite preserved ejection fraction is
associated with higher afterload and reduced
survival. Circulation 2007;115:2856–64.
5. Baumgartner H, Kratzer H, Helmreich G, Kühn P.
Determination of aortic valve area by Doppler
Baumgartner J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 1 0 , 2 0 1 5
Editorial Comment O C T O B E R 2 0 1 5 : 1 1 4 0 – 2
1142echocardiography using the continuity equation: a
critical evaluation. Cardiology 1990;77:101–11.
6. Tribouilloy C, Rusinaru D, Maréchaux S, et al.
Low-gradient, low-ﬂow severe aortic stenosis
with preserved left ventricular ejection fraction:
characteristics, outcome, and implications for
surgery. J Am Coll Cardiol 2015;65:55–66.
7. Clavel MA, Ennezat PV, Maréchaux S, et al.
Stress echocardiography to assess stenosis
severity and predict outcome in patients with
paradoxical low-ﬂow, low-gradient aortic stenosis
and preserved LVEF. J Am Coll Cardiol Img 2013;6:
175–83.
8. Chahal NS, Drakopoulou M, Gonzalez-
Gonzalez AM, Manivarmane R, Khattar R, Senior R.
Resting aortic valve area at normal transaortic
ﬂow rate reﬂects true valve area in suspected low-
gradient severe aortic stenosis. J Am Coll Cardiol
Img 2015;8:1133–9.
9. Blais C, Burwash IG, Mundigler G, et al. Pro-
jected valve area at normal ﬂow rate improves theassessment of stenosis severity in patients with
low-ﬂow, low-gradient aortic stenosis: the multi-
center TOPAS (Truly or Pseudo-Severe Aortic
Stenosis) study. Circulation 2006;113:711–21.
10. Ozkan A, Hachamovitch R, Kapadia SR,
Tuzcu EM, Marwick TH. Impact of aortic valve
replacement on outcome of symptomatic patients
with severe aortic stenosis with low gradient and
preserved left ventricular ejection fraction. Circu-
lation 2013;128:622–31.
11. Mehrotra P, Jansen K, Flynn AW, et al. Dif-
ferential left ventricular remodelling and longi-
tudinal function distinguishes low ﬂow from
normal-ﬂow preserved ejection fraction low-
gradient severe aortic stenosis. Eur Heart J
2013;34:1906–14.
12. Eleid MF, Sorajja P, Michelena HI, Malouf JF,
Scott CG, Pellikka PA. Flow-gradient patterns in
severe aortic stenosis with preserved ejection
fraction: clinical characteristics and predictors of
survival. Circulation 2013;128:1781–9.13. Vinco G, Bergamini C, Pighi M, Golia G,
Vassanelli C, Biancari F. Meta-analysis of the
outcome of patients with low gradient severe
aortic stenosis and preserved left ventricular
ejection fraction. Int J Cardiol 2013;168:
5076–8.
14. Clavel MA, Messika-Zeitoun D, Pibarot P, et al.
The complex nature of discordant severe calciﬁed
aortic valve disease grading: new insights
from combined Doppler echocardiographic and
computed tomographic study. J Am Coll Cardiol
2013;62:2329–38.
15. Clavel MA, Pibarot P, Messika-Zeitoun D, et al.
Impact of aortic valve calciﬁcation, as measured by
MDCT, on survival in patients with aortic stenosis:
results of an international registry study. J Am Coll
Cardiol 2014;64:1202–13.KEY WORDS aortic stenosis, ﬂow rate,
low-gradient, stress echocardiography
